/Investor DB

Sherpa Healthcare Partners

Venture capital

Zhuhai · Seed–Late Stage · 3 people tracked

Also known as SHERPA HEALTHCARE PARTNERS CO., LTD.

Find your way into Sherpa Healthcare Partners

Sign up to see every warm intro you have to Sherpa Healthcare Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sherpa Healthcare Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Sherpa Healthcare Partners is a leading venture capital firm dedicated to China's healthcare and life-science sector. It backs innovative companies across genomics, biopharmaceuticals, medical devices, gene and cell therapy, diagnostics, CRO/CDMO services, and healthcare delivery. The firm emphasizes independent domestic innovation, technically differentiated platforms, strong and experienced founding teams, and companies with global patents or internationally competitive technology. It supports portfolio companies from early stages through later growth rounds, aiming to help Chinese firms become leaders in their respective fields.

Source: firm website, verified Nov 10, 2026.

Stage
Seed–Late Stage
HQ
Zhuhai, CN
Leads rounds
Follows
Instruments
Equity
Founded
2018
Private fund assets
$269.4M
Tracked investments
35

Team · 3 people

from public directories
Daqing Cai· General Partner
Xiangyu Ouyang· General Partnerin
Darren Cai· Managing Partner

What they invest in

from 11 of 35 portfolio companies

Biotech ×11Healthtech ×8Deep Tech ×6Medical Devices ×4AI & Machine Learning ×2Advanced Manufacturing ×1Digital Health ×1FoodTech ×1

HQs:China×6United States×2Germany×1

Investments · 35 tracked

founders shown can be your intro path

By year:2022 · 32021 · 47 dated

Alebundalebund.cominSep 2021 · $54.5M

An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.

BiotechDigital HealthHealthtechMedical DevicesShanghai, CN

Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentYuanBio Venture Capital

Berry Genomicsberrygenomics.com

Gao Yang(Founder)Hou Ying(Founder)Zhou Daixing(Founder)

Co-investorsQiming Venture PartnersLegend Capital

Bota Biobota.bio

Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.

Advanced ManufacturingBiotechDeep TechFoodTechNew Materials

Dr. Cheryl Cui(CEO)

Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalMatrix Partners China

Cerberus Therapeuticscerberustx.cominDec 2021 · $4M

Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.

BiotechDeep TechHealthtechBoston, US

Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)

Co-investorsBill & Melinda Gates Foundation

ClinChoiceclinchoice.comin𝕏Jul 2022 · $150M

ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.

BiotechHealthtechMedical DevicesPhiladelphia, US

Dr. John Balian(CEO)

Co-investorsDFJ DragonFundDraper AssociatesDraper DragonApricot CapitalLegend CapitalLilly Asia Ventures

EdiGeneedigene.comApr 2021 · $62M

EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.

BiotechDeep TechHealthtech

Co-investorsLAVLilly Asia VenturesWI Harper Group3H Health InvestmentAlwin CapitalBioTrack Capital+2 more

EpimAb Biotherapeuticsepimab.com

Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.

BiotechHealthtechMedical DevicesShanghai, CN

Wu Chenbing(Founder/Expert)

Co-investorsDecheng CapitalShangBay Capital LLCTCG Labs3E Bioventures Capital

Neukioneukio.comSep 2022 · $50M

Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases.

BiotechDeep TechHealthtech

Liqun Wang(Founder)

Co-investorsPan-Lin CapitalAlwin CapitalIDG CapitalLilly Asia Ventures

Singleron Biotechnologiessingleronbio.comin𝕏Nov 2021

Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.

BiotechMedical DevicesCologne, DE

Nan Fang(PhD, MBA; CEO and Founder)inJing Zhou(PhD; CSO (co-founder))inRong Fan(Co-Founder of Singleron, Professor Yale University)in

Co-investorsARCH Venture PartnersLAVLilly Asia VenturesLake Bleu CapitalMSA CapitalSBCVC+1 more

Therornatherorna.comJun 2022 · $42M

Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs.

AI & Machine LearningBiotechDeep TechHealthtechBeijing, CN

Co-investorsCenova CapitalQuan Capital3H Health InvestmentMSA Capital

华辉安健(北京)生物科技有限公司huahuihealth.com

Huahui Health is a biotech company developing a pipeline of drug candidates targeting major liver diseases, with research rooted in the hepatitis B virus (HBV) infection mechanism.

BiotechHealthtechBeijing, CN

Dr. Li(Founder & Chairman of the Board)

新格元(南京)生物科技有限公司 (Singleron)singleron.bio

Singleron Biotechnologies develops single-cell sequencing technology and applies AI to support the development of next-generation medicines.

AI & Machine LearningBiotechDeep Tech

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Cytek Biosciences, Inc.EpimAb Biotherapeutics Inc. (岸迈生物)GIE Medical, Inc.Urotronic Inc.上海琪玑实业有限公司 (优仕美地)上海魅丽纬叶医疗科技有限公司信念医药科技(苏州)有限公司 (Belief BioMed)北京人人检科技有限公司北京六合宁远科技有限公司北京志道生物科技有限公司北京纳米维景科技有限公司北京艺妙神州医疗科技有限公司 (ImmuneOnco / Yimiao)南京红云生物科技有限公司国科恒泰(北京)医疗科技股份有限公司杭州健海科技有限公司武汉亚洲心脏病医院 (Wuhan Asia Heart Hospital)深圳北芯生命科技有限公司 (Insight Lifetech)珠海维视艾康特医药科技有限公司百力司康生物医药(杭州)有限公司 (Bliss Biopharmaceutical)盖睿医疗诺辉健康 (New Horizon Health)辉大(上海)生物科技有限公司 (HuidaGene)麦默真空技术无锡有限公司

Fund performance · per public LP disclosures · 3

as of Sep 2025
FundVintageCommittedNet IRRTVPIDPI
Sherpa Healthcare Fund IILPs: Oregon Public Employees Retirement System2021—2.5%1.08x0.10x
Sherpa Healthcare Co-Investment FundLPs: Oregon Public Employees Retirement System2020—-1.6%0.94x0.00x
Sherpa Healthcare Fund ILPs: Oregon Public Employees Retirement System2019—6.7%1.33x0.15x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has Sherpa Healthcare Partners made?
Sherpa Healthcare Partners has 35 tracked investments.
What stage does Sherpa Healthcare Partners invest at?
Sherpa Healthcare Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Sherpa Healthcare Partners focus on?
Sherpa Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is Sherpa Healthcare Partners located?
Sherpa Healthcare Partners is headquartered in Zhuhai, CN.
Does Sherpa Healthcare Partners lead rounds?
Sherpa Healthcare Partners typically participates in rounds rather than leading them.

Similar investors

Featured in lists